AzurRx BioPharma Announces Successful Phase IIa Trial of MS1819-SD in Exocrine Pancreatic Insufficiency
LAURION Broadens Advisor Network and Issues Stock Options to First Nations under Amended Exploration Agreement as Ishkoday Exploration Progresses